Pharmaceutical Marketing in Transition

Journal of Pharmaceutical Marketing and Management

Volumn 11, Issue 4, 1997, Pages 3-20

  Trombetta, William ^a   Cavanagh, Joan ^b  

^a FAIRLEIGH DICKINSON UNIVERSITY   (United States)

^b BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85018885349     PISSN: 08837597     EISSN: 15408574     Source Type: Journal    
DOI: 10.3109/J058v11n04_02     Document Type: Article

References (22)

1. Tully S. Why drug prices will go lower. Fortune 1993;13I(Feb I 0): 56 – 62.
2. Porter M. Competitive strategy. New York: Free Press, 1985.
3. O'Reilly B. Why Merck married the enemy. Fortune 1993;131(Sept 30): 60 – 4.
4. Freudenheim M. Merck's big gamble on a merger. New York Times 1993 Dec 8: D4.
5. Smith R. Filling prescriptions by mail: not always the best bargain. New York Times 1995 Jun 11: F9.
6. Solovy A. New power strategies. Hospitals Health Networks I 994;68(Dec 20): 24 – 34.
7. Wilcox T. Behavioral remedies in a post-Chicago world: it's time to revise the vertical merger guidelines. Antitrust Bull 1995; 40: 227 – 56.
8. Eli Lilly Decree. 59 Fed. Reg. 60,815. Antitrust Trade Reg Rep 1994;67. (consent decree)
9. Tanouye E. Owning Medco, Merck takes drug marketing the next logical step. Wall Street Journal 1994 May 31 At, A8.
10. Trombetta W. Channel systems: an idea whose time has come in health-care. I Health Care Market 1989;9(Oct): 26 – 35.
11. Petre P. How to keep customers happy captives. Fortune 1985;123(Jul 27): 42 – 6.
12. Caminiti S. Finding new ways to sell more. Fortune 1992;130(Sept 2): 100 – 3.
13. Harrar G. Pills 'n' pad no more. Forbes ASAP 1994;(Feb): 36 – 41.
14. Scott L. Suppliers feeling effects of Columbia. Mod Healthcare 1994;24(Mar 14): 22.
15. Bums A. Reinventing the detailer. Am Med News I993;36(May 17). 13 – 5.
16. Weisz P. Out of the lab and into the screening room. Brand Week 1994;35(Apr 18): 30 – 1.
17. Anders G. Managed healthcare jeopardizes outlook for drug detailers. Wall Street Journal 1993 Sept 10: Al, AS.
18. Mitka M. Drug makers move to shared risk to sell managed care. Am Med News 1994;37(Mar 7): 1, 9.
19. Thwaite E. Beat the generics by joining them. Med Market Media 1992;27(Sept): 110 – 22.
20. Hamilton I. Has Syntex run out of steam? Business Week 1993-,(301 12) 144 – 6.
21. Castognoli W. Hold it! Don't kill the sales budget. Med Market Media 1994;29(Apr): 12 – 6.
22. McCarren E. Rx to OTC switches: promises and pitfalls. Med Market Me-dia 1991;26(Sept): 12 – 26.